Cytokine imbalance in acute coronary syndrome

被引:41
作者
Alam, SE [1 ]
Nasser, SS [1 ]
Fernainy, KE [1 ]
Habib, AA [1 ]
Badr, KF [1 ]
机构
[1] Amer Univ Beirut, Ctr Med, Div Cardiol, Beirut, Lebanon
关键词
D O I
10.1016/j.coph.2003.10.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The excessive mortality of coronary heart disease is attributed primarily to rupture and thrombotic transformation of the atherosclerotic plaque. Inflammation plays a critical role in plaque destabilization and vulnerability. Inflammation is not confined to the culprit segment but is convincingly widespread in the coronary and remote vascular beds. Systemic inflammatory, thrombotic and hemodynamic factors are relevant to the pathological and clinical outcome. In addition to their fundamental role in thrombosis, there is ample evidence that platelets contribute significantly to promoting plaque inflammation. A new paradigm of unbalanced cytokine-mediated inflammation is emerging, providing diagnostic and therapeutic opportunity for intervention. Amplifying intrinsic anti-inflammatory mechanisms constitutes attractive avenues for future investigation.
引用
收藏
页码:166 / 170
页数:5
相关论文
共 50 条
  • [11] Morphological predictors of arterial remodeling in coronary atherosclerosis
    Burke, AP
    Kolodgie, FD
    Farb, A
    Weber, D
    Virmani, R
    [J]. CIRCULATION, 2002, 105 (03) : 297 - 303
  • [12] Vulnerable atherosclerotic plaque - A multifocal disease
    Casscells, W
    Naghavi, M
    Willerson, JT
    [J]. CIRCULATION, 2003, 107 (16) : 2072 - 2075
  • [13] Relation of inflammation and benefit of statins after percutaneous coronary interventions
    Chan, AW
    Bhatt, DL
    Chew, DP
    Reginelli, J
    Schneider, JP
    Topol, EJ
    Ellis, SG
    [J]. CIRCULATION, 2003, 107 (13) : 1750 - 1756
  • [14] PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway
    Chinetti, G
    Lestavel, S
    Bocher, V
    Remaley, AT
    Neve, B
    Torra, IP
    Teissier, E
    Minnich, A
    Jaye, M
    Duverger, N
    Brewer, HB
    Fruchart, JC
    Clavey, V
    Staels, B
    [J]. NATURE MEDICINE, 2001, 7 (01) : 53 - 58
  • [15] Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3
  • [16] Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques - Implications for plaque stabilization
    Crisby, M
    Nordin-Fredriksson, G
    Shah, PK
    Yano, J
    Zhu, J
    Nilsson, J
    [J]. CIRCULATION, 2001, 103 (07) : 926 - 933
  • [17] A major role for VCAM-1, but not ICAM-1, in early atherosclerosis
    Cybulsky, MI
    Iiyama, K
    Li, HM
    Zhu, SN
    Chen, M
    Iiyama, M
    Davis, V
    Gutierrez-Ramos, JC
    Connelly, PW
    Milstone, DS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (10) : 1255 - 1262
  • [18] Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol
    Dahlöf, B
    Devereux, RB
    Kjeldsen, SE
    Julius, S
    Beevers, G
    de Faire, U
    Fyhrquist, F
    Ibsen, H
    Kristiansson, K
    Lederballe-Pedersen, O
    Lindholm, LH
    Nieminen, MS
    Omvik, P
    Oparil, S
    Wedel, H
    [J]. LANCET, 2002, 359 (9311) : 995 - 1003
  • [19] Interleukin-7-mediated inflammation in unstable angina -: Possible role of chemokines and platelets
    Damås, JK
    Wæhre, T
    Yndestad, A
    Otterdal, K
    Hognestad, A
    Solum, NO
    Gullestad, L
    Froland, SS
    Aukrust, P
    [J]. CIRCULATION, 2003, 107 (21) : 2670 - 2676
  • [20] Chronic subclinical inflammation as part of the insulin resistance syndrome -: The Insulin Resistance Atherosclerosis Study (IRAS)
    Festa, A
    D'Agostino, R
    Howard, G
    Mykkänen, L
    Tracy, RP
    Haffner, SM
    [J]. CIRCULATION, 2000, 102 (01) : 42 - 47